The Board of Trustees of the Leland Stanford Junior University;Medicenna Therapeutics Inc.
发明人:
Kenan Christopher Garcia,Ignacio Moraga Gonzalez,Fahar Merchant
申请号：
US16470098
公开号：
US20200095301A1
申请日:
2017.12.14
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Methods and compositions are provided for enhancing anti-tumor effector immune cells with a targeting construct a human IL-13 superkine. Cytokine or additional co-stimulatory sequences may also be included to enhance the tumoricidal effects of the cells.
